1979
Multinational SmithKline & French (SK&F) enters Bangladesh
1990
Transcom acquires SmithKline & French (SK&F) and becomes Eskayef Bangladesh Ltd
2017
Eskayef Bangladesh Ltd. emerges as Eskayef Pharmaceuticals Ltd. to go more global
ABOUT
Eskayef Pharmaceuticals Ltd. is one of the leaders in Bangladesh’s pharmaceutical industry. With its presence across the world, it has earned coveted accreditations from the US FDA, UK MHRA, EU EMA, TGA Australia, and more. Eskayef spread its wings in 1990 when the Bangladeshi operations of SmithKline & French were acquired by Transcom Group.
Milestones
1999
- Pioneering of Pellet Technology in Bangladesh
2001
- Acquisition of Squibb Plant at Tongi
- Beginning of Animal Health Business
2003-2004
- Beginning of International Business
Global Quality Standards
International Accreditations
YEAR: 2022
YEAR: 2008, 2011, 2014, 2017
YEAR: 2011, 2014, 2017
Faraaz Ayaaz Hossain Building
Tablet, Capsule & Pellets (2017)
& Eskayef Oncology
Sterile injection & Oral Solid (2020)
YEAR: 2010, 2012, 2015
Eskayef Oncology
Sterile injection (2021)
Novo Nordisk
Servier
Eskayef exports to 67 countries
across 6 continents in the world.
Leadership Team
Simeen Rahman
Managing Director & CEO
Dr. Mohammad Mujahidul Islam
Executive Director - Marketing and Sales
Mohammed Ikhtiar Hossain
Executive Director - Technical Services
Md. Motiar Rahman
Executive Director - Quality Assurance
Mohammad Mostafa Hassan
Executive Director - Commercial & HR
Kazi Mahbub Masud
Executive Director - Finance
K.M. Ariful Islam
Executive Director - Plant
Abdullah Al Wahid
Executive Director - Plant
